Stock Recommendation

Moneycontrol

research

Our Research Team Covers 300 Companies Across 24 Sectors

Active Recommendations(0)
Closed Recommendations(2)

Search a Stock

Sectors

Sort by

Clear

Reco Date
Reco price
Earning growth

Reco Date	Stock Name	sector	View	Reco Price	Earning Growth (2 year expected CAGR)	Forward P/E The price to earnings ratio (P/E) measures the market’s valuation of a company relative to its annual net profits	Read Report

Search a Stock

Sectors

Sort by

Clear

Reco Date
Reco price
Exit Price
Exit Date
Returns

Reco Date	Stock Name	Sector	Reco Price	Exit Price	Exit Date	Last Recommendation	Returns
Aug 22, 2022	Hikal	Pharmaceuticals	315.00	279.35	Jul 26, 2023	overweight	-11.32 %
Jul 3, 2019	Hikal	Pharmaceuticals	169.00	514.00	Jan 11, 2022	overweight	204.14 %

Hikal

Pharmaceuticals

Reco Price (Aug 22, 2022) 315.00

Last Recommendation overweight

Exit Price (Jul 26, 2023) 279.35

Returns: -11.32 %

Hikal

Pharmaceuticals

Reco Price (Jul 3, 2019) 169.00

Last Recommendation overweight

Exit Price (Jan 11, 2022) 514.00

Returns: 204.14 %

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347